Delayed seroma formation secondary to docetaxel

Annals of Plastic Surgery

Volumn 50, Issue 4, 2003, Pages 429-432

  Sultan, Mark R ^a   Madhere, Shirley M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DOCETAXEL; DOXORUBICIN;

ADULT; ALOPECIA; ANEMIA; ANOREXIA; ARTHRALGIA; ARTICLE; ASCITES; ASPIRATION; ASTHENIA; BLOOD TOXICITY; BREAST CARCINOMA; BREAST RECONSTRUCTION; CASE REPORT; DESQUAMATION; DIARRHEA; DISEASE COURSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FLUID RETENTION; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERSENSITIVITY REACTION; INFLAMMATORY DISEASE; LATISSIMUS DORSI FLAP; MASTECTOMY; MOUTH MUCOSA; MUCOSA INFLAMMATION; MUSCULOSKELETAL DISEASE; MYALGIA; NAIL DISEASE; NAUSEA; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; ONYCHOLYSIS; PARESTHESIA; PERICARDIAL EFFUSION; PERIPHERAL EDEMA; PERIPHERAL VEIN INFLAMMATION; PLEURA EFFUSION; PRIORITY JOURNAL; RASH; SEROMA; SKIN MANIFESTATION; SKIN PLAQUE; STOMATITIS; SUBUNGUAL ERYTHEMA; SUBUNGUAL HEMORRHAGE; TASTE DISORDER; THROMBOCYTOPENIA; WEIGHT GAIN;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; MAMMAPLASTY; MIDDLE AGED; RECURRENCE; TAXOIDS; TIME FACTORS;

EID: 0037380478     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-200304000-00019     Document Type: Article

References (21)

1. Crown J, O'Leary M. The taxanes: an update. Lancet 2000;355:1176-1178
2. Cortes JE, Pazdur R. Docetaxel. J Clin Oncol 1995;13:2643-2655
3. Pronk L, Stoter G, Verweij J, et al. Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects. Cancer Treat Rev 1995;21:463-478
4. Shapiro JD, Millward MJ, Rischin D, et al. Activity and toxicity of docetaxel (Taxotere) in women with previously treated metastatic breast cancer. Aust NZ J Med 1997;27:40-44
5. Semb KA, Aamdal S, Oian P. Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol 1998;16:3426-3432
6. Oulid-Aissa D, Behar A, et al. Management of fluid retention syndrome in patients treated with Taxotere (docetaxel): effect of premedication. Proc ASCO 1994;13:465
7. Piccart MJ, Klijn J, Paridaens R, et al. Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer. J Clin Oncol 1997;15:3149-3155
8. Slavin SA. Drainage of seroma after latissimus dorsi myocutaneous flap breast reconstruction. Plast Reconstr Surg 1989;83:925-926
9. Menke HE, Erkens M, Olbrisch RR, et al. Evolving concepts in breast reconstruction with latissimus dorsi flaps: results and follow-up of 121 consecutive patients. Ann Plast Surg 2001;47:107-114
10. Rouzier R. [Autologous breast reconstruction with latissimus dorsi flap]. Ann Chir Plast Esthet 2000;45:583-588
11. Lin CH, Wei FC, Levin LS, et al. Donor-site morbidity comparison between endoscopically assisted and traditional harvest of free latissimus dorsi muscle flap. Plast Reconstr Surg 1999;104:1070-1077
12. Kat CC, Darcy CM, O'Donoghue JM, et al. The use of latissimus dorsi musculocutaneous flap for immediate correction of the deformity resulting from breast conservation surgery. Br J Plast Surg 1999;2:99-103
13. Delay EG, Gounot N, Bouillot A, et al. Autologous latissimus breast reconstruction: a 3-year clinical experience with 100 patients. Plast Reconstr Surg 1998;102:1461-1478
14. Delay EG, Gounot N, Bouillot A, et al. [Breast reconstruction with the autologous latissimus dorsi flap. Preliminary report of 60 consecutive reconstructions.] Ann Chir Plast Esthet 1997;42:118-130.
15. Schwabegger A, et al. Seroma as a common donor site morbidity after harvesting the latissimus dorsi flap: observations on cause and prevention. Ann Plast Surg 1997;38:594-597
16. Titley OG, et al. Preventing seroma in the latissimus dorsi flap donor site. Br J Plast Surg 1997;50:106-108
17. Moore T, Farrell L. Latissimus dorsi myocutaneous flap for breast reconstruction: long-term results. Plast Reconstr Surg 1992;89:666-672, Discussion 673-674
18. Reddick LP. Seroma after latissimus dorsi myocutaneous flap for breast reconstruction. Plast Reconstr Surg 1990;85:826
19. Roy MK, Shrotia S, et al. Complications of latissimus dorsi myocutaneous flap breast reconstruction. Eur J Surg Oncol 1998;24:162-165
20. Tschopp H. Evaluation of long-term results in breast reconstruction using the latissimus dorsi flap. Ann Plast Surg 1991;26:328-340
21. Peltoniemi H, Asko-Seljavaara S, et al. Latissimus dorsi breast reconstruction: long term results and return of sensibility. Scand J Plast Reconstr Hand Surg 1993;27:127-131